CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity

Nature

Volumn 420, Issue 6915, 2002, Pages 502-507

  Belkaid, Yasmine ^a   Piccirillo, Ciriaco A ^a   Mendez, Susana ^a   Shevach, Ethan M ^a   Sacks, David L ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGENS; CELLS; DISEASES; SKIN; STERILIZATION (CLEANING);

PATHOGENS;

IMMUNOLOGY;

CD4 ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 2 RECEPTOR;

HOST-PARASITE INTERACTION; IMMUNITY; INFECTIOUS DISEASE; PATHOGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE COURSE; IMMUNE RESPONSE; IMMUNITY; LATENT PERIOD; LEISHMANIA MAJOR; MOUSE; NONHUMAN; PARASITE IMMUNITY; PRIORITY JOURNAL; SKIN INFECTION; T LYMPHOCYTE;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; FLOW CYTOMETRY; INTERLEUKIN-10; LEISHMANIA MAJOR; LEISHMANIASIS, CUTANEOUS; MICE; MICE, INBRED C57BL; RECEPTORS, INTERLEUKIN-2; RECURRENCE; SKIN;

ANIMALIA; LEISHMANIA MAJOR;

EID: 2242423605     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/nature01152     Document Type: Article

References (26)

1. el Hassan, A. M. et al. Post kala-azar dermal leishmaniasis in the Sudan: Clinical features, pathology and treatment. Trans. R. Soc. Trop. Med. Hyg. 86, 245-248 (1992).
2. Momeni, A. Z. & Aminjavaheri, M. Clinical picture of cutaneous leishmaniasis in Isfahan, Iran. Int. J. Dermatol. 33, 260-265 (1994).
3. Alvar, J. et al. Leishmania and human immunodeficiency virus coinfection: The first 10 years. Clin. Microbiol. Rev. 10, 298-319 (1997).
4. Shevach, E. M. CD4+ CD25+ suppressor T cells: More questions than answers. Nature Rev. Immunol. 2, 389-400 (2002).
5. Sakaguchi,S., Sakaguchi, N., Asano, M., Itoh, M. & Toda, M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 155, 1151-1164 (1995).
6. Thornton, A. M. Shevach, E. M. CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J. Exp. Med. 188, 287-296 (1998).
7. Piccirillo, C. A. et al. CD4+CD25+ regulatory T cells can mediate suppressor function in the absence of transforming growth factorβ1 production and responsivenes. J. Exp. Med. 196, 237-246 (2002).
8. Papiernik, M., de Moraes, M. L., Pontoux, C., Vasseur, F. & Penit, C. Regulatory CD4 T cells: Expression of IL-2R alpha chain, resistance to clonal deletion and IL-2 dependency. Int. Immunol. 10, 371-378 (1998).
9. Belkaid, Y. et al. The role of interleukin (IL)-10 in the persistence of Leishmania major in the skin after healing and the therapeutic potential of anti-IL-10 receptor antibody for sterile cure. J. Exp. Med. 194, 1497-1506 (2001).
10. Belkaid, Y. et al. A natural model of Leishmania major infection reveals a prolonged 'silent' phase of parasite amplification in the skin before the onset of lesion formation and immunity. J. Immunol. 165, 969-977 (2000).
11. Piccirillo, C. A. & Shevach, E. M. Cutting edge: Control of CD8+ T cell activation by CD4+CD25+ immunoregulatory cells. J. Immunol. 167, 1137-1140 (2001).
12. Cederbom, L., Hall, H. & Ivars, F. CD4+CD25+ regulatory T cells down-regulate co-stimulatory molecules on antigen-presenting cells. Eur. J. Immunol. 30, 1538-1543 (2000).
13. + regulatory cells that control intestinal inflammation. J. Exp. Med. 192, 295-302 (2000).
14. Gazzinelli, R. T., Oswald, I. P., James, S. L. & Sher, A. IL-10 inhibits parasite killing and nitrogen oxide production by IFN-γ-activated macrophages. J. Immunol 148, 1792-1796 (1992).
15. Mendez, S. et al. The potency and durability of DNA- and protein-based vaccines against Leishmania major evaluated using low-dose, intradermal challenge. J. Immunol. 166, 5122-5128 (2001).
16. Karp, C. L. et al. In vivo cytokine profiles in patients with kala-azar. Marked elevation of both interleukin-10 and interferon-gamma. J. Clin. Invest. 91, 1644-1648 (1993).
17. Gasim, S. et al. High levels of plasma IL-10 and expression of IL-10 by keratinocytes during visceral leishmaniasis predict subsequent development of post-kala-azar dermal leishmaniasis. Clin. Exp. Immunol. 111, 64-69 (1998).
18. + T cells are important for the balance between protective and pathogenic cell-mediated immunity. J. Exp. Med. 179, 589-600 (1994).
19. + T cell clones producing both interferon-gamma and interleukin-10 predominate in bronchoalveolar lavages of active pulmonary tuberculosis patients. Clin. Immunol. 92, 224-234 (1999).
20. Plebanski, M. et al. Interleukin 10-mediated immunosuppression by a variant CD4 T cell epitope of Plasmodium falciparum. Immunity 10, 651-660 (1999).
21. -/-setting. Immunity 16, 429-439 (2002).
22. Ostrowski, M. A. et al. Quantitative and qualitative assessment of human immunodeficiency virus type 1 (HIV-1)-specific CD4+ T cell immunity to gag in HIV-1-infected individuals with differential disease progression: Reciprocal interferon-gamma and interleukin-10 responses. J. Infect. Dis. 184, 1268-1278 (2001).
23. Uzonna, J. E., Wei, G., Yurkowski, D. & Bretscher, P. Immune elimination of Leishmania major in mice: Implications for immune memory, vaccination, and reactivation disease. Immunol 167, 6967-6974 (2001).
24. O'Farrell, A. M., Liu, Y., Moore, K. W. & Mui, A. L. IL-10 inhibits macrophage activation and proliferation by distinct signaling mechanisms: Evidence for Stat3-dependent and -independent pathways. EMBO J. 17, 1006-1018 (1998).
25. von Stebut, E., Belkaid, Y., Jakob, T., Sacks, D. L. & Udey, M. C. Uptake of Leishmania major amastigotes results in activation and interleukin 12 release from murine skin-derived dendritic cells: Implications for the initiation of anti-Leishmania immunity. J. Exp. Med. 188, 1547-1552 (1998).
26. Lutz, M. B. et al. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J. Immunol. Methods 223, 77-92 (1999).